findmyKOL

Igor Barjaktarevic, MD

Enriched profile

HS Associate Clinical Professor of Medicine; Medical Director, COPD Program, David Geffen School of Medicine at UCLA · University of California, Los Angeles

ORCIDNPI
Region🇺🇸 Los Angeles, CA · West · United StatesSpecialtyPulmonary DiseaseFocusChronic Obstructive Pulmonary Disease (COPD) Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Igor Barjaktarevic is HS Associate Clinical Professor of Medicine; Medical Director, COPD Program, David Geffen School of Medicine at UCLA at University of California, Los Angeles. OpenAlex indexes 422 publications with 10,184 citations (h-index 37); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Igor Barjaktarevic, MD, MSC, is HS Associate Clinical Professor of Medicine at University of California, Los Angeles (David Geffen School of Medicine / UCLA Health, Ronald Reagan Medical Center). The public record shows 422 publications with 10,184 citations (h-index 37), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Asthma and respiratory diseases. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 14 companies.

  • Most recent indexed publication: 2026 · International journal of chronic obstructive pulmonary disease
  • Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
COPD6 trialsLung Diseases4 trialsEmphysema2 trialsRespiratory Insufficiency2 trialsBronchitis, Chronic1 trialBronchitis1 trialAirway Obstruction1 trialalpha 1-Antitrypsin Deficiency1 trialLung Cancer (NSCLC/SCLC)Asthma

Research focus

OpenAlex concept fingerprint
Chronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and MechanismsAsthma and respiratory diseasesInhalation and Respiratory Drug DeliveryLung Cancer Diagnosis and Treatment

Drugs & molecules

across trials, industry payments and publications
Ohtuvayregeneric · EnsifentrineClinical trialsIndustry payments12Publications2Prolastin-C LiquidClinical trialsIndustry payments51PublicationsDupixentgeneric · DupilumabClinical trialsIndustry payments25Publications

Works with

trial sponsors and companies reporting payments
Grifols USA, LLCClinical trialsIndustry payments51Genzyme CorporationClinical trialsIndustry payments29Verona Pharma, Inc.Clinical trialsIndustry payments12

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
422publications

Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.

10,184citations

Total citations across indexed works.

37h-index

Hirsch index (OpenAlex). i10-index 112.

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    100%
    Corticosteroid55.9%
    Trelegy Ellipta48%Fluticasone Propionate32%Breztri Aerosphere19%
    Part D<11 patients
    beta2-Adrenergic Agonist28.8%
    Albuterol Sulfate Hfa100%
    Part D14 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/igor-barjaktarevic-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/igor-barjaktarevic-md-phd-67404566

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Igor-Barjaktarevic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • X / Twitter

    x.com/Hananianick/status/1796371153122140193

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • PhD in Pulmonary Immunology

    University of Belgrade Faculty of Medicine

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • Board Certified

    Critical Care Medicine, American Board of Internal Medicine

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • Fellowship

    Pulmonary & Critical Care Medicine, New York Presbyterian Hospital/Weill Cornell Medical College

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • Board Certified

    Pulmonary Disease, American Board of Internal Medicine

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • MD

    University of Belgrade Faculty of Medicine

    2002
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • Residency

    Internal Medicine, New York University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org

Editorial & leadership roles

journal and society appointments
  • Committee member

    ATS/ERS 2019 "Standardization of Spirometry" technical statement

    2019
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thoracic.org
  • Medical Director

    COPD Program, David Geffen School of Medicine at UCLA

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • Director

    Bedside Ultrasound, Ronald Reagan Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.